RESMED INC. COMMON STOCK

ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024

01 авг 2024 15:05:01 Источник Nasdaq GlobeNewswire

ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024

03 июл 2024 15:05:00 Источник Nasdaq GlobeNewswire

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

10 июн 2024 08:05:00 Источник Nasdaq GlobeNewswire

Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy

23 май 2024 08:05:00 Источник Nasdaq GlobeNewswire

ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy

16 май 2024 15:35:00 Источник Nasdaq GlobeNewswire

ResMed Announces Participation in the RBCCM Global Healthcare Conference

07 май 2024 15:05:00 Источник Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024

25 апр 2024 15:05:01 Источник Nasdaq GlobeNewswire

ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024

04 апр 2024 15:05:00 Источник Nasdaq GlobeNewswire

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

15 мар 2024 02:05:00 Источник Nasdaq GlobeNewswire

Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask

06 мар 2024 08:05:00 Источник Nasdaq GlobeNewswire

ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea

12 фев 2024 15:16:33 Источник Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024

24 янв 2024 15:05:01 Источник Nasdaq GlobeNewswire

ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024

03 янв 2024 15:05:00 Источник Nasdaq GlobeNewswire

ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference

27 дек 2023 15:05:00 Источник Nasdaq GlobeNewswire

ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices

20 дек 2023 15:05:00 Источник Nasdaq GlobeNewswire

ResMed Secures Significant Victory in Patent Fight Against New York University

11 дек 2023 15:05:00 Источник Nasdaq GlobeNewswire

Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally

07 дек 2023 14:34:58 Источник Nasdaq GlobeNewswire

ResMed Adopts New Operating Model to Accelerate Long-term Growth

09 ноя 2023 15:05:02 Источник Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024

26 окт 2023 15:05:00 Источник Nasdaq GlobeNewswire

ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023

05 окт 2023 15:05:00 Источник Nasdaq GlobeNewswire